A major breakthrough in cancer research is emerging with the use of mini-antibodies to restore dysfunctional p53. This vital malignant inhibitor protein is frequently inactivated in many kinds of tumors, leading https://wildbookmarks.com/story22154772/mini-antibodies-reactivate-the-p53-protein-the-potential-hope-for-tumor-treatment